Publications by authors named "Bomassi E"

Introduction: Heart rate (HR) is often elevated in cats with cardiomyopathies (CMPs). Pharmacologic modulation of HR may reduce cardiac morbidity and mortality.

Objectives: To investigate the effects of cilobradine vs.

View Article and Find Full Text PDF

Introduction/objectives: Ebstein's anomaly (EA) is a congenital heart disease characterized by apical displacement of the tricuspid valve leaflets in the right ventricle. The objective of this retrospective study was to investigate the signalment, clinical features, echocardiographic findings, and outcome of dogs with EA.

Animals, Materials And Methods: Medical records of 40 dogs with EA were reviewed.

View Article and Find Full Text PDF
Article Synopsis
  • The EPIC study monitored dogs with myxomatous mitral valve disease (MMVD) to observe how they develop congestive heart failure (CHF).
  • It compared clinical and radiographic changes in dogs that developed CHF against those that did not, analyzing factors like heart rate and respiratory rate.
  • Key findings showed that dogs approaching CHF had significant increases in respiratory rates and heart rates, along with decreases in body weight and temperature, highlighting respiratory rates as crucial indicators of CHF onset.
View Article and Find Full Text PDF

Background: Heart disease is an important cause of morbidity and mortality in cats, but there is limited evidence of the benefit of any medication.

Hypothesis: The angiotensin-converting enzyme inhibitor benazepril would delay the time to treatment failure in cats with heart disease of various etiologies.

Animals: One hundred fifty-one client-owned cats.

View Article and Find Full Text PDF

Background: Changes in clinical variables associated with the administration of pimobendan to dogs with preclinical myxomatous mitral valve disease (MMVD) and cardiomegaly have not been described.

Objectives: To investigate the effect of pimobendan on clinical variables and the relationship between a change in heart size and the time to congestive heart failure (CHF) or cardiac-related death (CRD) in dogs with MMVD and cardiomegaly. To determine whether pimobendan-treated dogs differ from dogs receiving placebo at onset of CHF.

View Article and Find Full Text PDF

A 7-year-old castrated male Labrador retriever was examined for a 10-day history of weakness and syncope. Physical examination revealed bradycardia and a grade III/VI left apical systolic heart murmur. Electrocardiography demonstrated bradycardia, absence of P waves and an atrio-ventricular nodal escape rhythm.

View Article and Find Full Text PDF

A 5-year-old Belgian Malinois dog was presented for evaluation of dyspnea of 1-month duration. Tracheal intussusception was diagnosed by tracheoscopy. Treatment consisted of surgical resection of the invaginated tracheal ring and the immediate cranial and caudal tracheal rings.

View Article and Find Full Text PDF

OBJECTIVE To characterize the epidemiological, clinical, and echocardiographic features of dogs and cats with tetralogy of Fallot (TOF) and determine their survival times. DESIGN Retrospective case series. ANIMALS 15 dogs and 16 cats with a diagnosis of TOF as determined via echocardiography.

View Article and Find Full Text PDF

Background: Pimobendan is effective in treatment of dogs with congestive heart failure (CHF) secondary to myxomatous mitral valve disease (MMVD). Its effect on dogs before the onset of CHF is unknown.

Hypothesis/objectives: Administration of pimobendan (0.

View Article and Find Full Text PDF

Objective: To determine the signalment, clinical features, echocardiographic findings, and outcome of dogs and cats with ventricular septal defects (VSDs).

Design: Retrospective case series.

Animals: 56 dogs and 53 cats with VSDs.

View Article and Find Full Text PDF

Objective: To evaluate anaesthetic death after implementation of recommendations and its risk factors in a small animal practice.

Study Design: Observational cohort study.

Animals: All cats and dogs anaesthetized at the Centre Hospitalier Vétérinaire des Cordeliers during two periods, from April 15th, 2008 to April 15th, 2010 (period 1) and from June 15th, 2010 to August 24th, 2011 (period 2).

View Article and Find Full Text PDF

A 2-year-old male French bulldog was presented for investigation of lumbosacral pain and hindlimb ataxia associated with urinary and fecal incontinence. Survey radiography, myelography, and computed tomography images were suggestive of a dermoid sinus with associated spina bifida. Surgical intervention led to a resolution of pain and neurological deficits.

View Article and Find Full Text PDF

Objective: To determine the feasibility of thoracoscopic resection of masses located on the right auricle in dogs.

Design: Retrospective case series.

Animals: Dogs (n = 9) with a mass on the right auricle.

View Article and Find Full Text PDF

Objective: To evaluate the anaesthetic death risk for dogs and cats in a French private practice.

Study Design: Observational cohort study.

Animal Population: All small animals anesthetized at the Centre Hospitalier Vétérinaire des Cordeliers between April 15th, 2008 and April 15th, 2010.

View Article and Find Full Text PDF

This report describes a patent ductus arteriosus (PDA) in four puppies from the same family of Chihuahuas, bred from the same mother and from two different litters. Identification of this congenital anomaly relies on clinical examination, radiography and ultrasonography. Three of these puppies were female, and had a type-1 PDA.

View Article and Find Full Text PDF

Objectives: To describe a minimally invasive technique for treating urethral obstructions in male dogs and to review the postoperative results.

Methods: All dogs (n=9) had urethral obstruction due to calculi. Obstructions were verified by radiographic and ultrasonographic examinations.

View Article and Find Full Text PDF

Objective: To compare the efficacy and tolerability of the long-term administration of two different angiotensin-converting enzyme inhibitors, imidapril and enalapril, in a multicentric, prospective, randomized parallel-group scheme clinical trial in dogs with naturally acquired heart disease.

Animals: One hundred twenty eight dogs with clinical signs of heart failure (stage II (64-50%) - III (45-35%) - IV (19-15%) New York Heart Association) caused by chronic valvular disease or dilated cardiomyopathy were selected.

Procedure: Imidapril (minimum dosage 0.

View Article and Find Full Text PDF